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Abstract
In his original exposition of the biogenetic isoprenoid rule, L. Ruzicka noted the structural identity
between the fused A/B rings of triterpenoids/sterols and certain multicyclic diterpenoids as part of
the impetus leading to that profound insight. His prescient hypothesis that this chemical structure
relationship reflects similarities in the initial cyclization of these diterpenoids with that occurring
in triterpenoid biosynthesis has since been verified. However, this chemical structure relationship
does not continue to hold true for the additional rings found in many of these di- and tri- terpenoid
natural products. This is now appreciated to arise from differences in their subsequent biogenesis,
specifically further cyclization and/or rearrangement of these diterpenoids after formation of an
initial bicyclic intermediate in a separately catalyzed reaction. The trivial name for the
hydrocarbon skeleton of the most commonly found version of the corresponding unique
intermediate forms the basis for a unifying “labdane-related” designation. This defines a large
super-family of diterpenoids that contains nearly 7,000 already known natural products. Many of
these are found in plants, where the requisite biosynthetic machinery for gibberellin
phytohormones, particularly the relevant diterpene cyclases, provides a biosynthetic reservoir that
appears to have been repeatedly drawn upon to evolve new labdane-related diterpenoids. The
potent biological activity of the “ancestral” gibberellins, which has led to the independent
evolution of distinct gibberellin biosynthetic pathways in plants, fungi, and bacteria, is further
discussed as an archetypical example of the selective pressure driving the observed diversification
of the large super-family of labdane-related diterpenoid natural products.
1 Introduction
Natural products are generally classified on the basis of their biogenetic origins, leading to
the typical terpenoid/isoprenoid, phenylpropanoid, and alkaloid classifications, with the
constituent compounds further divided on the basis on their more specific origins; e.g.,
diterpenoids, flavonoids, and purine alkaloids.1 Of particular interest here are the
diterpenoids, derived from (E,E,E)-geranylgeranyl diphosphate (GGPP), which form a large
clan of >12,000 natural products.2 Notably, the diterpenoids can be further divided on the
basis of biogenetic hydrocarbon ring construction, with a significant fraction of the
polycyclic diterpenoids (~7,000) arising from dual, rather than single, biosynthetic
cyclization and/or rearrangement reactions, regardless of final number of rings. Here a
unifying labdane-related diterpenoid designation is proposed for these to reflect their distinct
biogenetic origins.
2 Unifying biogenetic origins of labdane-related diterpenoids
The identical stereochemical configuration of the bicyclic decalin ring structure at the core
of triterpenoid and certain diterpenoid natural products, specifically the trans nature of the
substituents on the bridging carbons (Figure 1), was noted as part of the impetus behind
development of the “biogenetic isoprene rule”.3 This was a prescient hypothesis that has
since been fully supported, including evidence for analogous cyclization mechanisms
leading to the decalin core ring structure.4 Specifically, the decalin ring structure is now
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known to be formed by a protonation-initiated, cationic cycloisomerization reaction in both
cases, while the differences in additional ring structure are further recognized as indicative
of their distinct biogenetic origins in the further cyclization of di- and tri- terpenoid natural
products. In particular, it has become apparent that this difference in subsequent ring
structure arises from the continuing nature of triterpenoid cyclization, while that of the
relevant polycyclic diterpenoids is carried out by two distinct mechanisms, as first suggested
by C. A. West.5 Initial cyclization is mediated by the aforementioned protonation-initiated
reaction, which most commonly results in a hydrocarbon skeletal structure analogous to the
labdanes, albeit with the diphosphate group remaining from the GGPP precursor, forming a
labdadienyl/copalyl diphosphate (CPP) intermediate. Accordingly, although not all natural
products sharing such dual cyclization reaction biogenetic origins are produced via this
particular intermediate, the labdane-related diterpenoid nomenclature presented here stems
from this distinctive structure. In the remainder of this section, the unifying biogenetic
origins of this super-family of natural product will be discussed in more detail. Given the
recent advances in this area, the characterization and/or identification of relevant enzymes is
specifically included here.
2.1 Initiating class II diterpene (bi)cyclization
The initiating and defining step in labdane-related diterpenoid biogenesis is the protonation-
initiated cyclization of GGPP, which proceeds via cationic carbon-carbon double bond
addition.6,7 Notably, although mono- or tri-cyclization does appear to be possible, there do
not appear to be any examples of corresponding natural products that are unambiguously
derived from such class II cyclization of GGPP rather than being degradative products of tri-
or tetra- terpenoids. Specifically, the monocyclic retinanes could be derived from
carotenoid-like tetraterpenes, and the tricyclic spongianes are likely degraded triterpenoid
quassinoids.8 Accordingly, this reaction has only been definitively shown to mediate
bicyclization of GGPP to a labda-13-en-8-yl+ diphosphate intermediate. The stereochemistry
of this intermediate depends on the pro-chiral conformation of the GGPP precursor upon
catalysis, albeit with the fixed trans configuration across the decalin bridgehead noted by
Ruzika that is imposed by the anti-parallel addition cyclization mechanism. In particular, a
pro-chair-chair conformation leads to copalyl of either normal, designated by comparison to
the stereochemistry of the analogous A/B rings in cholesterol,8 or antipodal/enantiomeric
(ent) stereochemistry, depending on absolute configuration, while a pro-chair-boat
conformation leads to syn orientation of the methyl and hydride substituents across the
C-9,10 bond, which can occur with either the normal or ent absolute configuration. These
various stereoisomers are most commonly quenched by deprotonation of the methyl group at
C-8, forming the exo-methylene of the previously noted CPP, whose stereochemistry is then
designated as normal, ent, syn, or syn-ent, respectively (Scheme 1).9 Notably, the most
commonly observed variant is ent-CPP, with many such class II diterpene cyclases
known,10–25 particularly from plants where they are required for gibberellin phytohormone
metabolism (as discussed in Section 4). Normal CPP also is quite common, with several
such enzymes known,26–31 while syn-CPP is much less common and only a few such
enzymes are known.32 By contrast, the production of syn-ent-CPP has not been observed,
and only natural products from plants of the Calceolaria genus have been rigorously
demonstrated to have such stereochemistry.33 Notably, the defining stereochemistry at C-9
and C-10 of the corresponding CPP often remains unchanged in the extended families of
derived labdane-related diterpenoid natural products, enabling assignment of the
corresponding biosynthetic intermediate with some confidence.
Beyond simply generating CPP by the cycloisomerization reaction described above, class II
diterpene cyclases also are capable of generating further chemical diversity. In particular, it
is possible for the initially bicyclized labda-13-en-8-yl+ diphosphate carbocation to be
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captured by water prior to deprotonation, leading to hydroxylated variants (labda-13-en-8-ol
diphosphate with the hydroxyl in either the α or β position). Presumably, such quenching is
most readily achieved by anti-parallel addition of the water, such that hydroxyl group
stereochemistry is at least biased, if not dictated, by GGPP pro-chiral configuration. Indeed,
class II diterpene cyclases catalyzing this type of cyclohydration produce a compound with
just such stereochemistry, specifically labda-13-en-8α-ol diphosphate of normal
configuration (Scheme 2).34
This class II (bi)cyclization reaction also is capable of generating further hydrocarbon
skeletal diversity, as the initially formed labda-13-en-8-yl+ diphosphate intermediate can
undergo a series of 1,2-hydride and/or methyl shifts, much like those observed in the
analogous triterpenoid cyclization reactions,35 with the full series forming the clerodane
hydrocarbon backbone. These migrations do not appear to be concerted, as the only
identified class II diterpene cyclase that produces a clerodadienyl/terpentedienyl diphosphate
contains an anti arrangement of methyl substituents on C-8 and C-9 that must arise from syn
hydride/methyl migration.36 In addition, the last methyl shift also does not appear to be
restricted to anti-parallel migration, as cis and trans arrangements of the substituents on the
bridging C-5/C-10 are known in natural products from the clerodane family, with production
of the alternative cis bridgehead arrangement within the class II cyclization reaction enabled
by the presence of geminal methyl groups on C-4, which allows alternative migrations
dictating the configuration of the resulting bridgehead. Furthermore, this series of shifts can
be interrupted at various stages by quenching of the relevant carbocationic intermediate,
most commonly by deprotonation of a neighboring endo-methylene, leading to a series of
rearranged isoprenyl diene diphosphate compounds (Scheme 3), albeit with retention of the
bicyclic decalin core. The most easily recognized variant is that corresponding to the
halimadane backbone, resulting from single hydride and methyl migrations. The double
bond isomers of halimadienyl diphosphate can be generated by deprotonation either before
or after hydride migration from C-5 to C-10, and a bacterial class II diterpene cyclase that
produces halima-5,13-dienyl diphosphate (i.e. post-C5,10 hydride shift) has been
identified.37
Intriguingly, there is strong evidence for B-ring contraction proceeding from the preceding
haliman-13-en-5-yl+ diphosphate intermediate in plueromutulin biosynthesis,38 providing an
example of how this reaction may be used to generate even more diverse hydrocarbon
backbone structures (Scheme 4). Indeed, several alternative such ring rearrangements may
be catalyzed by class II diterpene cyclases (e.g. in portulal biogenesis). Finally, while it
should be possible to generate further chemical diversity by capture of any of these
carbocation intermediates with water prior to deprotonation (much as described above), it
does not appear that any such class II diterpene cyclases have been characterized.
2.2 Subsequent class I diterpene synthase transformations
Class II cyclization reactions leave intact in the resulting bicyclic isoprenyl the allylic
diphosphate ester linkage from the GGPP precursor. This is then utilized by terpene
synthases analogous to those operating in terpenoid biosynthesis more generally,39 to
catalyze lysis/ionization-initiated, cationic cyclization and/or rearrangement reactions.
Notably, the terpene synthases operating in labdane-related diterpenoid biosynthesis
specifically act upon the bicyclic isoprenyl diphosphate precursors formed by the upstream
class II diterpene cyclases. In particular, these class I diterpene synthases are generally much
less reactive with the more universal diterpenoid precursor GGPP, and other acyclic
isoprenyl diphosphates, although they may react with a range of class II diterpene cyclase
products (e.g., two different stereoisomers of CPP).40 The hydrocarbon backbone structure
formed by these class I diterpene synthases typically remains largely unchanged in the
derived natural products, providing the basis for their assignment into families of
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biogenetically related natural products. A number of such skeletal structures are described in
Section 3 below, and the corresponding class I reaction mechanisms will be discussed there.
Here it is simply noted that there are a significant number of such backbone structures
known, particularly when differences in sterochemical configuration are further taken into
account. Finally, it should also be noted that the various carbocation intermediates in these
class I reactions also can be captured by water prior to deprotonation, just as described
above for the class II reactions, with the additional possibility of (re)capture of the ionized
pyrophosphate anion, as described for the monoterpene cyclase bornyl diphosphate
synthase,41 although no other terpenoid has yet been characterized as having an analogous
biogenetic origin.
2.3 Further elaboration
Much of the diversity in any group of terpenoid natural products arises from the tailoring
reactions that decorate the basic hydrocarbon backbone,1 and the labdane-related
diterpenoids are no exception. Accordingly, while the primary focus of this review is the
unifying nature of their biogenetic origins, the range and type of downstream modifications
will be briefly mentioned here. Such modification almost invariably is initiated by the
insertion of oxygen catalyzed by a cytochrome P450 monooxygenase. The resulting
hydroxyl then provides a target for further transformations, most generally, addition of
functional groups. These range from a simple methyl or acetate group to amino acids,
sugars, and fatty acids, with the labdane-related diterpenoids able to further form part of
more complex (meroterpenoid) natural products, such as the indole diterpenoid alkaloids.2
The appended functional groups can be targeted for further transformations and/or addition,
providing even more, albeit auxiliary chemical diversity. Ultimately, it is these tailoring
reactions that produce the wide range of observed labdane-related natural products, with
differences in resulting structure defining the ~7,000 individual members of this super-
family. It also should be noted here that these downstream transformations can lead to
rearrangement of the hydrocarbon backbone structure formed by the initiating dual
cyclization reactions described above, obscuring assignment of the resulting natural
product(s) to a particular family, although this can, and in many cases has been worked out,
as will be described for the ent-kaurene derived gibberellin phytohormone and oryzalide
phytoalexin families below (Section 3.5).
3 Prototypical labdane-related diterpenoids
To provide an overview of the labdane-related diterpenoids, and particularly the unifying
biogenetic origins of the hydrocarbon backbone that defines the constituent families of
natural products, a number of the most common are presented here, along with the relevant
class I cyclization reaction mechanisms and, where known, the corresponding enzymes.
3.1 Bicyclic: Labdanes, clerodanes, and others
The most basic hydrocarbon backbones in the labdane-related diterpenoid super-family are
the bicyclic such natural products, which include the labdane, clerodane and halimadane
families. As described above, the underlying ring structure is formed by the relevant class II
diterpene cyclase, with the relevant class I diterpene synthases presumably then simply
removing the diphosphate without catalyzing cyclization. Most typically, it would be
expected that this results in an olefin via direct deprotonation of the initially formed allylic
cation, typically at the neighboring endo-methylene or methyl. For example, enzymes
forming syn-labda-8(17),12E,14-triene and clerodatriene/terpente-3,13(16),14-triene have
been identified (Scheme 5).36, 40 In addition, just as described for the class II diterpene
cyclases, it is possible for this intermediate to be captured by water prior to deprotonation,
yielding a hydroxylated diterpenoid, and a class I diterpene synthase catalyzing just such a
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reaction has been very recently identified (personal communication; M. Schalk, Firmenich).
Notably, while further cyclization of rearranged class II bicycles seems possible (e.g. with
halimadienyl diphosphate), this has only been specifically invoked in the case of
pleuromutilin biosynthesis (Scheme 4). Thus, the overwhelming majority of further cyclized
labdane-related diteprenoids are derived from the various stereoisomers of CPP.
3.2 Tricyclic: Pimaranes, abietanes, and others
Given that further cyclization seem to almost invariably proceed from CPP, attack of the
initially formed allylic carbocation on the C-8(17) carbon-carbon double bond inevitably
occurs via Markovnikov addition, reflecting the much more favorable formation of a tertiary
versus primary carbocation. This can occur via either si-face or re-face attack/addition,
leading to alternative configurations of the geminal methyl/vinyl pair at C-13 of the resulting
pimara-15-en-8-yl+ intermediate,9 with the α-methyl/β-vinyl configuration considered
normal (which seems to be based on early studies of resin acid configuration) and the
inverse β-methyl/α-vinyl the epi/isomeric form. Direct deprotonation of this carbocationic
intermediate from any of the neighboring endo-methylenes yields various double bond
isomers of (iso)pimaradiene (Scheme 6). Class I diterpene synthases catalyzing the
production of pimaradienes or isopimaradienes from normal, ent-, and syn-CPP have been
identified.28, 40, 42–45
Even beyond these various (iso)pimaradienes, other tricycles are known, arising from
rearrangement of the initially (tri)cyclized (iso)pimara-15-en-8-yl+ intermediate prior to
quenching of a terminal carbocation.8, 9 The most trivial example arises from a 1,2-hydride
shift, followed by deprotonation of a neighboring endo-methylene, yielding a 9(11)-double
bond isomer of (iso)pimaradiene, with one such class I diterpene synthase already
identified.22 More interestingly, the various corresponding carbocation intermediates can
undergo further rearrangements. The pimara-15-en-14-yl+ intermediate resulting from C14,8
hydride transfer can lead to a 1,2-shift of either substituent from the neighboring C-13, with
methyl migration forming cassa-15-en-13-yl+ and vinyl migration isocassa-15-en-13-yl+
intermediates, followed by direct deprotonation to form the corresponding diene, and an ent-
cassa-12,15-diene synthase has been identified (Scheme 7).46 Notably, C9,8 hydride transfer
can initiate a series of 1,2 methyl and hydride migrations analogous to the rearrangements
discussed for class II reactions above (i.e., those leading to clerodanes; Scheme 8). Methyl
migration from C-10 to C-9 forms a rosa-15-en-10-yl+ intermediate, with ensuing 1,2
hydride transfer leading to a rosa-15-en-5-yl+ intermediate, either of which can be
deprotonated on a neighboring endo-methylene to form the corresponding diene. Finally, the
latter intermediate can undergo a 1,2 methyl transfer to form a dolabra-15-en-4-yl+
intermediate that can either be directly deprotonated to the corresponding diene, or form a
cyclopropyl ring by deprotonation of the delocalized methyl in the process of migrating,
yielding the tetracycle devadarene. However, it must be noted that no enzymes catalyzing
any of the 1,2 methyl/hydride shift mediated rearrangements discussed above appear to have
been characterized to date.
By contrast, it has been shown that the initially formed pimara-15-en-8-yl+ intermediate can
undergo a 1,4 proton transfer (C-14,16) to produce a pimara-8(14)-en-15-yl+ intermediate
that can undergo rearrangement.47 In particular, a 1,2 methyl migration to form
abieta-8(14)-en-13-yl+, which can be deprotonated in variety of positions to form the
relevant dienes (Scheme 9).48 Several such class I diterpene synthases have been
indentified,26, 28, 29 including one suggested to catalyze 1,5 proton transfer in order to
produce abieta-8,12-diene (miltiradiene).31 Alternatively, the C-ring of the pimara-8(14)-
en-15-yl+ intermediate can undergo ring expansion and deprotonation of the neighboring
endo-methylene to form stroba-8(15),12-diene, although it does not appear that an enzyme
catalyzing such a reaction has yet been characterized.
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3.3 Tetracyclic: Kauranes, beyeranes, and others
Given that tricyclization generally occurs from CPP to form (iso)pimarenyl+ intermediates,
tetracycles are then formed by attack of the terminal C-16 methylene of the C-13 vinyl
group on either C-8 or, following C-9,8 hydride transfer, C-9 (Scheme 10).9 Given the
potential for four different stereoisomers of CPP, and potential si-face or re-face
tricyclization to eight different variants of (iso)pimarenyl+, there are then sixteen different
potential tetracycles. In addition, these tetracyclic intermediates can then undergo additional
rearrangement, potentially leading to at least 75 different skeletal structures, although only
some of these have been actually shown to occur. Here only several examples will be
presented in an attempt to provide an overview of the potential types of tetracycles, with a
focus on those with known biogenetic relevance.
Starting from the ent-pimara-15-en-8-yl+ intermediate arising from re-face tricyclization of
ent-CPP, tetracyclization connecting C-16 to C-8 forms a ent-beyer-15-yl+ intermediate,
which can be directly deprotonated on the neighboring endo-methylene to form ent-
beyer-15-ene. Alternatively, the secondary carbocation ent-beyer-15-yl+ intermediate can
undergo ring rearrangement (Scheme 11). Intriguingly, this proceeds via a delocalized
carbocationic intermediate, which can be directly deprotonated to the pentacycle
trachylobane, or yield tertiary carbocation intermediates by either undergoing a 1,2 hydride
shift and ring arrangement to form ent-atisir-16-yl+ or more straightforward single bond
shift to form ent-kaur-16-yl+. In both of the latter two cases, these tertiary carbocations can
be directly deprotonated at either the neighboring methyl or endo-methylene, to yield the
corresponding double bond isomers. Of particular interest, deprotonation of ent-kaur-16-yl+
on the neighboring methyl group gives rise to the ent-kaur-16-ene relevant to gibberellin
phytohormone biosynthesis, while deprotonation of the neighboring endo-methylene yields
ent-isokaur-15-ene. Given the role of ent-kaurene synthases in gibberellin phytohormone
metabolism, it is present in all higher plants, the implications of which are described below
(Section 4), and many such enzymes have already been identified.19, 21, 24, 25, 45, 49–51
Notably, these selectively produce ent-kaur-16-ene, while selective ent-isokaur-15-ene
synthases also have been identified.44, 45 Furthermore, it is possible to add water prior to
deprotontation, to form ent-kaur-16-ol, and a diterpene synthase catalyzing such product
outcome has been identified as well.52 In addition, a mutant ent-pimaradiene synthase has
been found to produce some ent-atisir-16-ene,53 with both ent-beyerene and trachylobane
synthase activity having been characterized in castor bean.54 An equivalent series of
transformations is known for cyclization of normal CPP, with pimar-15-en-8-yl+ derived
kaur-16-ene known, and a diterpene synthase producing the isopimar-15-en-8-yl+ derived
phyllocladan-16-ol has been identified.30
Examples of C-9,16 tetracyclization arise from both re- and si-face tricyclized syn-CPP
following C-9,8 hydride shift within the corresponding (iso)pimaryl+ intermediates (Scheme
12). The secondary carbocationic intermediate formed by such tetracyclization seems to
typically undergo ring rearrangement to a tertiary carbocationic intermediate, although its
direct deprotonation also is plausible. In the case of the tetracycle derived from syn-
pimar-15-en-9-yl+, formation of an aphidicol-16-yl+ intermediate is known. In particular,
this intermediate can undergo direct deprotonation at either the neighboring methyl or endo-
methylene, to yield the corresponding double bond isomers, and a mutant syn-pimaradiene
synthase has been shown to selectively produce aphidicol-15-ene.55 Alternatively, this
intermediate can undergo addition of water prior to deprotonation, and such an
aphidicolan-16-ol forming diterpene synthase has been identified.32 The tetracycle derived
from syn-isopimar-15-en-9-yl+ is known to undergo ring rearrangement from either of the
neighboring endo-methylenes, with that from C-12 leading to a stemar-13-yl+ with a 6-6-5-6
ring structure analogous to that found in aphidicolanes, while ring rearrangement from C-14
results in stemodan-16-yl+, and both are observed to be directly deprotonated on the
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neighboring methyl or endo-methylene to the corresponding double bond isomers. Class I
diterpene synthases forming either syn-stemodene and/or syn-stemarenes, more or less
selectively, have been identified.56, 57 Formation of a 6-6-6-5 ring structure analogous to
that of syn-stemarene from the tetracycle derived from syn-pimar-15-en-9-yl+ also is
possible. Finally, an equivalent series of transformations can be envisioned for cyclization of
syn-ent-CPP, with enantiomeric labdane-related diterpenoids having been isolated from
Calceolaria species.33
3.4 Pentacyclic: Trachylobanes and Helifulvanes
The formation of pentaycles occurs by deprotonation of delocalized rearrangements of the
tetracycles, inevitably leaving a cyclopropyl ring.8, 9 The example of ent-trachylobane,
derived from the delocalized ring rearrangement intermediate following C-8,16
tetracyclization, was described above (Scheme 11). Similarly, the pentacycle ent-helifuvane
arises from C-9,16 tetracyclization and deprotonation of an analogous delocalized ring
rearrangement intermediate (Scheme 13). However, while natural products with a
helifulvane hydrocarbon backbone are known, in no such class I diterpene synthase activity
been characterized.
3.5 Subsequent hydrocarbon backbone alterations: Gibberellins and Oryzalides
As noted above (Section 2.3), downstream transformations can alter the hydrocarbon ring
structure formed by the initiating dual cyclization and/or rearrangement reactions. Both ring
contraction and expansion are thought to occur. An example of ring expansion seems to
arise from the presumably ent-atisirene derived aconitine diterpenoid crypto-alkaloid.58
More is known about the ring contraction reaction catalyzed in gibberellin metabolism.59 In
particular, gibberellins are derived from ent-kaur-16-ene, with the ‘B’ ring of this 6-6-6-5
tetracycle contracted to a five membered ring to form the characteristic 6-5-6-5 ring
structure of the gibberellins. This occurs following initial oxidation to ent-kaur-16-en-19-oic
acid, with ‘B’ ring contraction occurring during the subsequent oxidation of the C-7 endo-
methylene to a carboxylic acid, with both sets of oxidative reactions catalyzed by a
cytochrome P450 mono-oxygenase, ent-kaurene oxidase and ent-kaurenoic acid oxidase,
respectively. Accordingly, ring contraction is thought to be mediated by formation of a
radical intermediate at C-6, with a 1,2 radical shift leading to extrusion of the previously
formed C-7β-ol, and resulting in an aldehyde product (Scheme 14).9
In addition to such direct ring rearrangements, it is possible for substitution within a
carbocycle of the original hydrocarbon backbone to lead to heterocycle formation. An
example of this can be seen in the antibacterial oryzalides found in rice.60, 61 These appear
to be ent-isokaur-15-ene derived nor-diterpenoid natural products wherein C-2 of the ‘A’
ring has been substituted by an oxygen. Derivation of the oryzalides from ent-isokaurene
can be readily discerned from the co-occurring oryzalic acids, wherein the ‘A’ ring has been
fractured by the oxidation of both C-2&3 to carboxylic acids (Figure 2).61, 62
4 Gibberellin phytohormone biosynthesis as a genetic reservoir
Among the labdane-related diterpenoids, the gibberellin phytohormones stand out for their
critical role in normal plant growth and development. The requirement for gibberellin
metabolism in all higher plants thus provides a genetic reservoir of biosynthetic genes from
which other such natural products can and have been evolved. Not surprisingly then, the
majority of labdane-related diterpenoids are found in plants. Gibberellin biosynthesis
proceeds via cyclization of GGPP to ent-CPP and, hence, to the 6-6-6-5 tetracycle ent-
kaurene, which is further oxidized to ent-kaurenoic acid prior to formation of the
characteristic 6-5-6-5 gibberellin ring structure via oxidation of the C-7 endo-methylene to a
Peters Page 7
Nat Prod Rep. Author manuscript; available in PMC 2013 September 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
carboxylic acid, as described above. Accordingly, the three early biosynthetic steps, i.e.
those prior to formation of the gibberellin ring structure, provide direct access to ent-kaurene
derived compounds (Scheme 15). Indeed, the more than 1,000 known such natural products
are consistent with facile evolution of such alternative labdane-related diterpenoid
biosynthesis.
Broader diversity also is readily accessible. For example, it has been shown that the ent-
kaurene synthases found in all higher plants due to their necessary role in gibberellin
biosynthesis can be converted to the production of tricyclic pimaradienes by a single amino
acid change.53 In addition, the converse change can alter product outcome from a tricycle to
tetracycle,55 and this single residue switch appears to be broadly applicable to class I
diterpene synthase catalysis.63 Newly arisen labdane-related diterpenes might be recognized
and oxygenated, increasing their polarity, solubility, and, hence, potential for exerting
biological activity, either directly by the kaurene oxidase cytochrome P450 from gibberellin
biosynthesis, or by other cytochromes P450 in the producing organisms. In this regard, it is
notable that plants have vastly expanded numbers of cytochrome P450 mono-oxygenases in
their genomes,64 providing a ready source of potential such downstream acting enzymes.
While the model plant Arabidopsis thaliana is thought to make only gibberellins, and not
other labdane-related diterpenoids, rice (Oryza sativa) provides a model system that has long
been recognized to make other such natural products.65 Recent work in rice is then
providing insights into the evolution of alternative labdane-related diterpenoid biosynthesis
from ancestral gibberellin metabolism. From comprehensive characterization of the class II
and class I families of diterpene synthases, their homologous origins are readily evident.66
The rice class II diterpene cyclases have evolved such that even though there are two ent-
CPP synthases, only one seems to play a role in gibberellin metabolism,67 with the other
presumably required for alternative labdane-related diterpenoid biosynthesis,17 exhibiting
closer homology to the syn-CPP synthase that must operate in such alternative
metabolism.17, 18, 68 The rice class I diterpene synthases, while also all sharing homologous
origins, have undergone more chemically divergent evolution, and produce a wide array of
labdane-related diterpenes derived from the endogenous ent- or syn-CPP.42–46, 56, 57 Indeed,
it was the functional genomics based investigations of the varied product outcome mediated
by these rice ent-kaurene synthase-like paralogs that led to the insights into class I diterpene
synthase plasticity discussed above, as well as resulting in identification of a number of
novel such enzymes. Intriguingly, indirect evidence further suggests that some of the
kaurene oxidase paralogs found in the rice genome might similarly act in such alternative
labdane-related diterpenoid biosynthesis.69 Accordingly, work in rice has demonstrated the
divergence of all three early acting enzymes from gibberellin metabolism to alternative
labdane-related diterpenoid biosynthesis following gene duplication events, consistent with
the derivative evolutionary scenario presented here (Scheme 15).
5 Driving diversity: Biological activity
While the discussion above emphasizes the facility with which alternative labdane-related
diterpenoid biosynthesis can be derived from gibberellin metabolism, the fact that
Arabidopsis lacks such expanded biosynthetic processes highlights the fact that this does not
necessarily lead to such evolution, which must be driven by selective pressure. For example,
the rice labdane-related diterpenoid natural products whose evolutionary origins are
discussed above have putative roles as antimicrobial phytoalexins and/or neighboring plant
growth suppressing allelochemicals.66 The selective pressure for retention of such metabolic
capacity in rice is notably reflected in the fact that its genome contains two clusters of
unrelated genes for labdane-related diterpenoid biosynthesis,16, 41, 68, 69 which is an unusual
occurrence in plants that is associated with strong biological activity.70 Given the need for
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selective pressure to drive the evolution of alternative labdane-related diterpenoids, the large
number of such natural products suggests that their underlying hydrocarbon skeletal
structures might serve as privileged scaffolds from which biological activity is readily
derived.
5.1 Repeated evolution of gibberellin biosynthesis
Perhaps the most striking example of the ability of selective pressure to drive natural
products evolution arises from the intriguing observation that the potent effect of
gibberellins on plant physiology have led to their production by not only plants, but plant
associated microbes as well, both fungal and bacterial,71 with each of the relevant biological
kingdoms appearing to have independently evolved such capacity.21 In all three cases,
GGPP is cyclized to ent-kaurene, and it has been suggested that the relevant diterpene
synthases may share some distant homologous origins.21 However, the remaining steps in
fungal gibberellin biosynthesis are mediated by four cytochromes P450, which mediate early
C-3 hydroxylation, along with a hydrocarbon desaturase.72 By contrast, the oxidative steps
in plant gibberellin metabolism are catalyzed by a mixture of cytochromes P450 and 2-oxo-
glutarate dependent dioxygenases, with C-3 hydroxylation occurring as the last step in
production of the bioactive gibberellin phytohormones.73 Finally, while much less is known
about bacterial GA production, it appears that only three cytochromes P450 and a short
chain alcohol dehydrogenase are required.21 Notably, even in the case of the relevant
cytochromes P450, across the various kingdoms these mono-oxygenases share no more than
15% amino acid sequence identity, while those involved in fungal gibberellin biosynthesis
share more identity, indicating more homology between these consecutively acting enzymes
than with their functional analogs from the other kingdoms. Thus, gibberellin biosynthesis in
plants, fungi, and bacteria clearly represents an example of convergent metabolic evolution.
Independent assembly of these complex multistep pathways is consistent with strong
selective pressure for such biosynthesis arising from the potent effects of the bioactive
gibberellins on plant physiology.
6 Conclusions
Based on their common biogenetic origins in the initiating dual cyclization and/or
rearrangement reactions described above, a unifying labdane-related diterpenoid designation
has been proposed here for the corresponding super-family of natural products. Intriguingly,
while diterpene synthases catalyzing some of the possible cyclization and/or rearrangement
reactions have been identified, many remain unknown. Even for those already identified, the
enzymatic structure-function relationships underlying catalysis of what are often complex
cyclization and rearrangement reactions, but which nevertheless generally lead to specific
product outcome, is largely unknown, providing a rich area for continued investigation, as
does study of the downstream tailoring enzymes.
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